Neovacs SA (FR:ALNEV) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Neovacs SA has announced a fundraising initiative of €0.25 million through the issue of OCEANE-BSA securities to finance their Kinoïde research program and bolster investment in biotech and medtech projects. The fundraising could potentially create 500 million new shares, diluting current shareholders’ stakes. The company focuses on developing vaccine candidates and investing in high-potential biotech and medtech companies.
For further insights into FR:ALNEV stock, check out TipRanks’ Stock Analysis page.